Galena Biopharma In (GALE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GALE | AEON | CMMB | ||
| Company | Galena Biopharma In | Aeon Biopharma Inc | Chemomab Therapeutics Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.29 | 1.0600 | 2.0502 | ||
| High | 0.40 | 1.1200 | 2.0502 | ||
| Low | 0.26 | 1.0400 | 1.7900 | ||
| Latest | 0.26 | 1.0500 | 1.8800 | ||
| Change | -0.02 | +0.0200 | -0.0200 | ||
| % Change | -7.14% | +1.94% | -1.05% | ||
| Volume | 20,353,201 | 133,900 | 102,300 | ||
| 20-Day Average Volume | 1,645,400 | 165,755 | 98,810 | ||
| Previous Close | 0.28 | 1.0300 | 1.9000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.28 | 0.8701 | 2.2930 | ||
| 20-Day Raw Stochastic | 0.00% | 83.31% | 14.42% | ||
| 20-Day Relative Strength | 39.37 | 58.28 | 32.87 | ||
| Weighted Alpha | -71.76 | -48.76 | -77.42 | ||
| Today's Opinion | N/A | 88% Buy | 100% Sell | ||
| Previous Opinion | N/A | 88% Buy | 100% Sell | ||
| Last Month's Opinion | N/A | 32% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.45% since 12/22/17 | +8.25% since 12/17/25 | -9.62% since 12/17/25 | ||
| Low | 0.26 on 12/29/17 | 0.9400 on 12/18/25 | 1.7300 on 12/19/25 | ||
| High | 0.40 on 12/29/17 | 1.1300 on 12/19/25 | 2.2399 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | -16.40% since 11/29/17 | +27.29% since 11/24/25 | -21.99% since 11/24/25 | ||
| Low | 0.26 on 12/29/17 | 0.6507 on 12/05/25 | 1.7300 on 12/19/25 | ||
| High | 0.40 on 12/29/17 | 1.1300 on 12/19/25 | 2.7700 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | -26.35% since 09/29/17 | +34.17% since 09/24/25 | -27.69% since 09/24/25 | ||
| Low | 0.26 on 12/29/17 | 0.6507 on 12/05/25 | 1.7300 on 12/19/25 | ||
| High | 0.44 on 10/10/17 | 1.4145 on 10/17/25 | 3.5800 on 10/07/25 | ||
| 6-Month | |||||
| %Chg | -55.17% since 06/29/17 | +48.31% since 06/24/25 | -60.83% since 06/24/25 | ||
| Low | 0.26 on 12/29/17 | 0.6252 on 08/12/25 | 1.7300 on 12/19/25 | ||
| High | 0.65 on 07/03/17 | 1.4145 on 10/17/25 | 4.9200 on 07/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,885 | 12,193 | 11,695 | ||
| Shares Outstanding, K | 45,710 | 11,838 | 6,155 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -23,550,000 | 42,010,000 | -13,950,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -6,080,000 | -4,540,000 | -1,740,000 | ||
| 60-Month Beta | 1.99 | 0.75 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 08/14/17 | -0.39 on 11/14/25 | -0.36 on 08/14/25 | ||
| Latest Earnings Date | 03/21/18 | 03/23/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.39 | 0.00 | ||